About Medifast Inc
- Industry: Consumer products
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://medifastinc.com/
Frequently Asked Questions
What is the 52-week range for MED?
The 52-week high is $14.15 and the 52-week low is $9.22.
What is the P/E ratio for MED?
The P/E ratio data is currently unavailable.
What is the dividend yield for MED?
The indicated annual dividend yield is 9.97%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -12.68%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -8.08%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.59.
Analyst Recommendation Trends
Wall Street analyst consensus for MED over the last few months:
Latest MED News
Q2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care Segment
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers.
Will Innovation and Digital Expansion Efforts Drive Clorox's Growth?
CLX's innovation, GOJO acquisition and digital transformation are strengthening its health and hygiene portfolio while supporting long-term growth.
Here's Why Shares of BranchOut Food Surge 89% in a Year
BOF's 89% rally reflects expanding ingredient sales, recurring retail programs and rising factory utilization that could support margin recovery.
What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
Baltimore, MD, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The signs of poor metabolic health can be difficult to analyze without a clinical framework. Trilivy™, a science-backed, coach-guided metabolic health system, points to five frequently overlooked patterns adults can recognize before noticeable weight and energy fluctuations. "Few people encounter a working definition of metabolic health before a diagnosis makes it necessary. Until then, progress is often measured by body weight, a number that leav
Hormel Foods Pricing Strategy: Can It Balance Value and Profitability?
HRL is using pricing, mix, efficiency and cost discipline to improve profitability as value-focused consumers reshape demand.
Why Weight Loss Plateaus Happen: 5 Metabolic Causes
Trilivy™ is designed to address the challenges of metabolic dysfunctionClients on Trilivy's Reset 5 & 1 Plan who work with a coach lose up to 10 times more weight and 17 times more fat compared to self-directed approaches* Baltimore, MD, Sept. 29, 2026 (GLOBE NEWSWIRE) -- A weight loss plateau is one of the most common reasons people abandon a structured weight loss effort altogether. The body stops losing weight when metabolic dysfunction interferes with the fat-burning process, and without a f
Can Hormel Foods' Protein Portfolio Win Over Value-Seeking Consumers?
HRL's protein portfolio is gaining momentum as brands meet demand for affordable, convenient and versatile food choices.
Boston Beer Uses Innovation, Pricing & Brand Investments for Growth
SAM's innovation, brand investments and productivity efforts aim to drive growth and margin expansion as demand remains challenging.
Constellation Brands' Premiumization and Innovation Aid Growth
STZ's premium portfolio and beer leadership continue to fuel growth as it doubles down on innovation and premiumization.
Is Laird Superfood (LSF) Stock Outpacing Its Consumer Staples Peers This Year?
Here is how Laird Superfood, Inc. (LSF) and Medifast (MED) have performed compared to their sector so far this year.
1 Unpopular Stock That Should Get More Attention and 2 We Turn Down
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
MNST's International Sales Surge 35%: Is Global Expansion Paying Off?
Monster Beverage's international sales surge in Q2 as growth in China, India and Brazil broadens its overseas engine despite margin pressures.
Medartis Group acquires M.A.R.C. Institute to establish its first surgical education center in the US
The Medartis Group today announced the acquisition of the M.A.R.C. Institute in Doral, Florida, one of the largest surgical training and bioskills research facilities in the world. The institute will retain its name and continue to operate under its existing leadership.
Will Strategic Initiatives and Pricing Strength Boost Clorox's Growth?
CLX's margin management, innovation and IGNITE strategy support growth, while cost pressures and value-conscious consumers challenge its progress.
Can Colgate Revive North America Growth in the Second Half?
CL is betting on premium innovation, higher ad spending and targeted pricing to revive North America growth after a weak second quarter.
AVO Q3 Earnings Beat on Farming Strength and Calavo Contribution
Mission Produce's Q3 revenues climb as avocado volumes surge, but lower pricing squeezes margins while Calavo boosts distribution results.
Premiumization and Strong Brands Fuel Constellation Brands' Growth
STZ's premium strategy, strong beer portfolio and brand investments position it for market share gains and long-term growth.
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth?
MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater efficiency and a return to profitability.
BellRing Brands (BRBR) Down 15% Since Last Earnings Report: Can It Rebound?
BellRing Brands (BRBR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-26 | Kiai Parsa | +1,175 | $12.2632 | $14,409 |
| 2026-08-26 | Kiai Parsa | +41,975 | $12.2632 | $514,748 |
| 2026-08-24 | Kiai Parsa | +118 | $11.9996 | $1,416 |
| 2026-08-24 | Kiai Parsa | +4,211 | $11.9996 | $50,530 |
| 2026-08-20 | Kiai Parsa | +1,175 | $11.6037 | $13,634 |
| 2026-08-20 | Kiai Parsa | +41,975 | $11.6037 | $487,065 |
| 2026-08-19 | Kiai Parsa | +799 | $11.6576 | $9,314 |
| 2026-08-19 | Kiai Parsa | +28,538 | $11.6576 | $332,685 |
| 2026-05-26 | Rose Jeffrey Matthew | +6,739 | - | - |
| 2026-05-26 | Rose Jeffrey Matthew | +11,680 | - | - |
| 2026-05-26 | Geary Elizabeth A. | +11,680 | - | - |
| 2026-05-26 | Thomas Andrea B | +11,680 | - | - |
| 2026-05-26 | Kiai Parsa | +7,637 | - | - |
| 2026-05-26 | Kiai Parsa | +11,680 | - | - |
| 2026-05-26 | Xian Ming | +11,680 | - | - |
| 2026-05-26 | SCHLACKMAN SCOTT | +11,680 | - | - |
| 2026-05-11 | SCHLACKMAN SCOTT | +2,500 | $12.53 | $31,325 |
| 2026-05-08 | SCHLACKMAN SCOTT | +2,500 | $12.65 | $31,625 |
| 2026-03-25 | MacKenzie Jonathan Barrett | +10,830 | - | - |
| 2026-03-25 | MacKenzie Jonathan Barrett | -862 | $9.59 | $8,267 |
| 2026-03-25 | Maloney James P. | +1,014 | - | - |
| 2026-03-25 | Maloney James P. | +34,344 | - | - |
| 2026-03-25 | Maloney James P. | -3,224 | $9.59 | $30,918 |
| 2026-03-25 | Chard Daniel R | +4,827 | - | - |
| 2026-03-25 | Chard Daniel R | +36,968 | - | - |
| 2026-03-25 | Chard Daniel R | -20,095 | $9.59 | $192,711 |
| 2026-03-20 | Chard Daniel R | +17,678 | $10.11 | $178,725 |
| 2026-03-17 | MacKenzie Jonathan Barrett | -70 | $10.05 | $704 |
| 2026-03-17 | Maloney James P. | -482 | $10.05 | $4,844 |
| 2026-03-17 | Chard Daniel R | -2,638 | $10.05 | $26,512 |
| 2026-03-13 | MacKenzie Jonathan Barrett | -198 | $9.62 | $1,905 |
| 2026-03-13 | Maloney James P. | -918 | $9.62 | $8,831 |
| 2026-03-13 | Chard Daniel R | -7,075 | $9.62 | $68,062 |